JMCP Research Highlight: Hypoclycemia, A1C Control, and Adherence Affect Costs for Patients with Type 2 Diabetes in a Real-World Population
While improved adherence to diabetes medications is associated with higher drug costs, it also is associated with lower inpatient, outpatient and emergency room costs, according to a study in this month’s
AMCP Applauds Introduction of the “Pharmaceutical Information Exchange (PIE) Act of 2017”
The Academy commends Rep. Brett Guthrie (R-KY) for introducing H.R.2026, the "Pharmaceutical Information Exchange (PIE) Act of 2017."
AMCP Foundation Announces Recipients of 2017 National P&T Competition, Best Poster Contests
Denver, Colo., March 30, 2017 — The AMCP Foundation is proud to announce winners of its 17th Annual National Student Pharmacist Pharmacy & Therapeutics (P&T) Competition and 2017 Best Poster Contests for student pharmacists, residents or fellows, and graduate students. Winning the P&T Competition was the University of North Carolina Eshelman School of Pharmacy. Winner of the Best Student Pharmacist Poster was Arianna Kee; Best Resident or Fellow Poster was Kameron Kelly, PharmD; and Best Graduate Student Poster was Sanket Shah, MBBS.
AMCP Foundation Board of Trustees Swears in New Member, Summerpal Kahlon, MD
Denver, Colo., March 30, 2017 — The Academy of Managed Care Pharmacy (AMCP) Foundation is pleased to announce the addition of Summerpal Kahlon, MD, to its Board of Trustees.
Managed Care Pharmacy Leaders Honored at Academy of Managed Care Pharmacy/AMCP Foundation Awards Dinner
Denver, Colo., March 30, 2017 — The Academy of Managed Care Pharmacy and AMCP Foundation honored some of managed care pharmacy’s brightest leaders last night at the Annual Award Dinner. Eight awards were presented at the gala event held March 29 as part of the AMCP Managed Care & Specialty Pharmacy Annual Meeting in Denver, Colorado.
Academy of Managed Care Pharmacy Opens AMCP Managed Care & Specialty Pharmacy Annual Meeting
Denver, Colorado, March 28, 2017 — Four thousand managed care pharmacy professionals and stakeholders from across the country have traveled to Denver, Colorado, this week for the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting.
AMCP Members Urge Congress, Administration to Include Comprehensive Pharmacy Benefit in Reform Plan
Managed care pharmacy professionals have the expertise necessary to help lawmakers develop policies for an effective pharmaceutical benefit under any new health care reform bill that may emerge in the weeks and months ahead. That was the key message delivered over the past two days by the Academy of Managed Care Pharmacy (AMCP) at its Annual Legislative Days.
AMCP Foundation Executive Director Paula Eichenbrenner Named ‘Young & Aspiring’ Association Executive by Association TRENDS Magazine
Eichenbrenner was one of five individuals selected for this prestigious national award, presented since 1998 to the brightest rising stars of the association community.
This Month’s Journal of Managed Care & Specialty Pharmacy Focuses on Optimizing Outcomes in Oncology
February’s themed issue of the Journal of Managed Care & Specialty Pharmacy examines challenges that managed care pharmacists face in administering oncology therapies, including considerations around patient-reported outcomes and the role of caregivers.
Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) Announces Addition of Apobiologix to Consortium
The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) is pleased to announce the addition of a new participating organization, Apobiologix.
AMCP Praises FDA’s Guidance on Communications Between Biopharmaceutical Companies and Population Health Decision Makers; Guidance Largely Aligns With AMCP Recommendations
The Academy commends the FDA for its release today of draft guidance clarifying how biopharmaceutical companies and population health decision makers can proactively share clinical and economic information on both FDA approved products as well as emerging therapies awaiting FDA approval.
AMCP Releases Consensus Recommendations Proposing the Creation of a Safe Harbor for Preapproval Information Exchange (PIE)
The Academy has released a set of consensus recommendations to allow biopharmaceutical companies to proactively share clinical and economic information with population health decision makers on emerging therapies in advance of FDA approval, an area that is significantly restricted by current federal laws and FDA regulations.